Inflammation-Induced Lethargy Is Mediated by Suppression of Orexin Neuron Activity

Abstract

In response to illness, animals subvert normal homeostasis and divert their energy utilization to fight infection. An important and unexplored feature of this response is the suppression of physical activity and foraging behavior in the setting of negative energy balance. Inflammatory signaling in the hypothalamus mediates the febrile and anorectic responses to disease, but the mechanism by which locomotor activity (LMA) is suppressed has not been described. Lateral hypothalamic (LHA) orexin (Ox) neurons link energy status with LMA, and deficiencies in Ox signaling lead to hypoactivity and hypophagia. In the present work, we examine the effect of endotoxin-induced inflammation on Ox neuron biology and LMA in rats. Our results demonstrate a vital role for diminished Ox signaling in mediating inflammation-induced lethargy. This work defines a specific population of inflammation-sensitive, arousal-associated Ox neurons and identifies a proximal neural target for inflammatory signaling to Ox neurons, while eliminating several others.

Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6

“…The 11-fold elevation of IL-6 mRNA in the hypothalamus after the central GLP-1R stimulation was nearly twofold that previously reported after an LPS challenge (48). In fact, this places EX4 as one of the most potent known inducers of hypothalamic IL-6.…”

Cytotoxic chemotherapy increases sleep and sleep fragmentation in non-tumor-bearing mice

“…Examination of the relationship between chemotherapy-induced cytokine expression and fatigue may provide further insight into the mechanism underlying sleep disruption. Indeed, suppression of the hypothalamic orexin arousal system appears to be one of the downstream mechanisms through which chemotherapy-induced central inflammation increases fatigue Grossberg et al, 2011). Chemotherapy treated mice display reduced orexin neuron activity that correlates with fatigue; furthermore, chemotherapy-induced fatigue can be attenuated via exogenous orexin-a administration .…”

Fatigue in multiple sclerosis – Insights into evaluation and management

“…Decreased and increased levels of orexin-A are essential to respectively promote consolidated night sleep and daytime activity [98]. Admitting the suppression effect that could be exerted by neuroinflammation on the orexin-A system [79], alteration of the latter might occur in MS and could lead to sleep disturbance and fatigue. Exploration of orexin-A system is possible via CSF analysis, a procedure requiring a lumbar puncture which renders it difficult to perform, and can explain the rarity of clinical data in this field.…”